ALTAMIRA THERAPEUTICS LTD (CYTOF)
Institutional ownership reported to the SEC as of Q2 2026, across 9 quarters.
1
Reporting holders
$0
Reported value
0.0%
Held as options
+0
Holder change
Options share is the part of reported value carried in derivative lines rather than shares. A high figure means institutions are expressing a view on this security without owning much of it.
Holders
| Filer | Value | Shares | Their book | Held | Change |
|---|---|---|---|---|---|
| LRI Investments, LLC | $0 | 1 | 0.00% | new | NEW |
Quarter by quarter
Coverage begins with the quarter ending 2018-12-31. Earlier filings exist only as occasional late amendments, too sparse to describe a market, so they are not shown.
| Quarter | Holders | Value | Shares | New | Added | Trimmed | Options |
|---|---|---|---|---|---|---|---|
| Q2 2026 | 1 | $0 | 1 | 1 | 0 | 0 | 0.0% |
| Q4 2024 | 1 | $1.2K | 10,926 | 1 | 0 | 0 | 0.0% |
| Q3 2024 | 4 | $71.3K | 116,261 | 3 | 0 | 0 | 0.0% |
| Q2 2024 | 4 | $3.0K | 2,659 | 2 | 0 | 0 | 0.0% |
| Q1 2024 | 3 | $3.5K | 1,675 | 0 | 1 | 0 | 0.0% |
| Q4 2023 | 4 | $26.7K | 7,680 | 4 | 0 | 0 | 0.0% |
| Q1 2022 | 1 | $7.0K | 0 | 0 | 0 | 0 | 100.0% |
| Q4 2021 | 2 | $76.0K | 0 | 2 | 0 | 0 | 100.0% |
| Q3 2021 | 1 | $13.0K | 0 | 2 | 0 | 0 | 100.0% |